湖北省卫健委下达违规配额指令 强推公立医院采购本地药企产品
Hubei health commission coerces public hospitals into procuring favored local drugs through illegal quota directives
- 湖北省卫健委下发机密采购指令，强制公立医院用本地国有药企产品替换已被临床验证有效的常规药品。 Hubei Provincial Health Commission issued confidential procurement directives forcing public hospitals to replace clinically proven medications with local state-owned drug brands.
- 抵制配额指标的公立医院院长面临纪律审查及财政预算削减威胁。 Hospital directors who resisted quotas faced disciplinary audits and budget reductions.
- 凸显了地方经济保护主义如何为了提振地方财税，不惜牺牲患者的医疗健康福祉。 Highlights regional economic protectionism compromising patient health outcomes to boost municipal tax receipts.
据《财新》报道，湖北省卫健委制定了一份偏向本地26家药企的专属采购目录，并通过动态追踪配额，强迫全省二级和三级公立医院采购本地药物。卫生官员将医院管理层的考核考评与本地药品的销售指标直接挂钩，挤占了原本性价更高、在全国广泛使用的正规治疗药物。
这一指令展示了通过行政强制推行的地方保护主义。省市两级行政机构惯于操弄官僚保护主义垄断，迫使医疗机构将本地受扶持企业的利益置于患者照护与成本效益之上。在剥夺临床自主权且缺乏司法独立来约束行政滥权的情况下，医疗机构沦为地方经济利益偏袒的工具，最终代价则由患者承担。
The Hubei Provincial Health Commission established a proprietary procurement catalog favoring 26 local pharmaceutical manufacturers, forcing secondary and tertiary public hospitals across the province to buy local medications through tracked quotas, Caixin reported. Health officials tied hospital executive reviews to regional sales targets, displacing lower-cost national treatments.
The directive demonstrates regional protectionism executed through administrative coercion. Municipal and provincial bureaus routinely cartelize local markets, compelling medical institutions to prioritize favored domestic suppliers over patient care and cost efficiency. Without judicial independence to check bureaucratic mandates, healthcare providers remain instruments of local economic favoritism at the expense of patient outcomes.
医疗论坛丁香园上的医生们表达了隐秘的无奈：“医生被强迫开具疗效较差的本地配方药品，仅仅是为了帮地方官员完成省里的GDP考核指标。”
Physicians on medical forum DXY (丁香园) voiced quiet despair: 'Doctors are forced to prescribe inferior local pharmaceutical formulas just so regional officials hit provincial GDP quotas.'
湖北省卫健委下发紧急内部通知，严禁医护人员向媒体记者泄露药品采购配额相关信息。
Hubei provincial health commission issued urgent internal notices barring hospital staff from leaking procurement quotas to journalists.
中国药品供应链中的地方保护主义，屡屡迫使三甲医院用未经充分临床检验的本地国企产品替换已在全国广泛验证的成熟药物。
Local protectionism (地方保护主义) in China's drug supply chain often forces tertiary hospitals to replace proven national medications with unproven local SOE products.